Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Esperion Therapeutics, Inc.
Type
Public
Traded as NASDAQ: ESPR
Industry Pharmaceutical
Founded May 1998 (1998-05)
Founder
  • Roger Newton
  • Tom Rea
  • Michael Pape
  • Charlie Bisgaier
Headquarters Plymouth, Michigan, U.S.
Key people
Roger S. Newton (President & CEO)
Net income
  • Decrease(US$26.1 million) (2013)
  • (US$11.7 million) (2012)
Total assets
  • IncreaseUS$78.3 million (2013)
  • US$7.31 million (2012)
Website Esperion.com
Footnotes / references
financial information

Esperion Therapeutics, Inc. is a public, American pharmaceutical company focused on the development of LDL-C-lowering therapeutics with potential for treatment of hypercholesterolemia and other cardiometabolic conditions. The company is headquartered in Plymouth, Michigan.

Investment goal date:
Dividends reinvested
Esperion Therapeutics, Inc. ESPR report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-02-27
--
--
Q3 2017
2017-11-01
0.0000
0.0000
Q2 2017
2017-08-08
-1.9200
-1.9200
Q1 2017
2017-05-04
-1.8000
-1.8000
Q4 2016
2017-02-22
-1.2900
-1.2900
Q3 2016
2016-11-03
-0.7700
-0.7700
Q2 2016
2016-08-04
-0.6200
-0.6200
Q1 2016
2016-05-04
-0.6500
-0.6500
Q4 2015
2016-02-25
-0.5800
-0.5800
Q3 2015
2015-11-05
-0.5700
-0.5700
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Aisling Capital LLC
837125
Arrowpoint Asset Management, LLC
1207916
BlackRock Fund Advisors
789210
BlackRock Inc.
1281944
Boxer Capital, LLC
1275000
CREDIT SUISSE AG/
878824
FMR LLC
1308588
Numeric Investors LLC
1219931
Opaleye Management Inc.
1215000
Pentwater Capital Management LP
1836200
PINNACLE ASSOCIATES LTD
770618
RA CAPITAL MANAGEMENT, LLC
704701
Redmile Group, LLC
4325055
Vanguard Group, Inc
724150
WASATCH ADVISORS INC
766543
Major Shareholders
Name Relationship
Total Shares
Holding stocks
TREU JESSE I
0.2300% (35253)
BLAIR JAMES C
0.2300% (35253)
GOLDSTEIN DOV A MD
5.4200% (837125)
OMENN GILBERT S
0.0100% (1000)
AMGN / ESPR / GALT /
VITULLO NICOLE
0.2300% (35253)
JANNEY DANIEL
10.2900% (1588627)
ESPR / NEOT / VIVE /
DOVEY BRIAN H
0.2300% (35253)
SCHOEMAKER KATHLEEN K
0.2300% (35253)
LANGE LOUIS G
1.2800% (197703)
BOLD / CBAY / ESPR /
NEWTON ROGER S
4.0800% (629683)
ESPR /
MAYLEBEN TIMOTHY M
0.2700% (41614)
ASTM / ESPR / LOXO / MRNS /
MCGOVERN MARK E
0.0300% (5000)
ESPR /
ENRIGHT PATRICK G
0.1200% (18361)
CORT / ESPR / JAZZ /
Aisling Capital II LP
11.8900% (1837125)
CEMP / ESPR /
Halak Brian K
0.2300% (35253)
DP VII ASSOCIATES LP
0.2300% (35253)
DOMAIN PARTERS VII L P
14.3500% (2216935)
Alta Partners VIII, L.P.
11.0700% (1709967)
Longitude Capital Partners, LLC
0.1800% (28186)
ESPR /
% ()